Evidence map›Paper›PMID 27410035›Full record

ArticlePloS one2016

An APC/C-Cdh1 Biosensor Reveals the Dynamics of Cdh1 Inactivation at the G1/S Transition.

Andrej Ondracka, Jonathan A Robbins, Frederick R Cross

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrej OndrackaLaboratory of Cell Cycle Genetics, The Rockefeller University, New York, NY 10065, United States of America.
Jonathan A RobbinsLaboratory of Cell Cycle Genetics, The Rockefeller University, New York, NY 10065, United States of America.
Frederick R CrossLaboratory of Cell Cycle Genetics, The Rockefeller University, New York, NY 10065, United States of America.
Rockefeller University · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Sources and Consequences of noise in cell cycle regulationR01GM078153 · NIGMS · ROCKEFELLER UNIVERSITY · PI CROSS, FREDERICK R. · 2006 to 2019
$3.3M
NIAID NIH HHS T32 AI007061NIGMS NIH HHS R01 GM078153NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

B-type cyclin-dependent kinase activity must be turned off for mitotic exit and G1 stabilization. B-type cyclin degradation is mediated by the anaphase-promoting complex/cyclosome (APC/C); during and after mitotic exit, APC/C is dependent on Cdh1. Cdh1 is in turn phosphorylated and inactivated by cyclin-CDK at the Start transition of the new cell cycle. We developed a biosensor to assess the cell cycle dynamics of APC/C-Cdh1. Nuclear exit of the G1 transcriptional repressor Whi5 is a known marker of Start; APC/C-Cdh1 is inactivated 12 min after Whi5 nuclear exit with little measurable cell-to-cell timing variability. Multiple phosphorylation sites on Cdh1 act in a redundant manner to repress its activity. Reducing the number of phosphorylation sites on Cdh1 can to some extent be tolerated for cell viability, but it increases variability in timing of APC/C-Cdh1 inactivation. Mutants with minimal subsets of phosphorylation sites required for viability exhibit striking stochasticity in multiple responses including budding, nuclear division, and APC/C-Cdh1 activity itself. Multiple cyclin-CDK complexes, as well as the stoichiometric inhibitor Acm1, contribute to APC/C-Cdh1 inactivation; this redundant control is likely to promote rapid and reliable APC/C-Cdh1 inactivation immediately following the Start transition.

Indexed as

Anaphase-Promoting Complex-CyclosomeBacterial ProteinsBiosensing TechniquesCdh1 ProteinsCell Cycle CheckpointsCell Cycle ProteinsCyclin BCyclin-Dependent KinasesKaryopherinsLuminescent ProteinsMicrotubule-Associated ProteinsPhosphorylationSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinationAcm1 protein, S cerevisiaeAnaphase-Promoting Complex-CyclosomeAse1 protein, S cerevisiaeBacterial ProteinsCdh1 ProteinsCDH1 protein, S cerevisiaeCell Cycle ProteinsCyclin BCyclin-Dependent KinasesKaryopherinsLuminescent ProteinsMicrotubule-Associated ProteinsMSN5 protein, S cerevisiaeSaccharomyces cerevisiae Proteinsyellow fluorescent protein, Bacteria

Identifiers

PMID27410035
PMCPMC4943722
OpenAlexW2467160242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.